Clinical Trial Update: A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 trial evaluating apatinib in combination with S-1 for advanced gastric cancer; the status is listed as UNKNOWN with no results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN